Monday, February 24, 2025
Home Tags CSL – Seqirus

Tag: CSL – Seqirus

Australia extends life-saving antivenom partnership with PNG

Australia is bolstering its support for Papua New Guinea's health system by renewing its partnership, which includes supplying antivenom doses and training healthcare workers, for an additional three years until 2027.

CSL’s $800 million vaccine manufacturing facility in Melbourne nears completion

CSL Seqirus has reached a major milestone in the construction of its new cutting-edge manufacturing facility for vaccine and antivenom manufacturing. 

TGA approves domestic manufacture of AstraZeneca vaccine

CSL has been given the nod by the Therapeutic Goods Administration (TGA) to commence the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. TGA’s...
Advertisement

Golden Beach Fencing

Com2 Communications

Power Machinery Australia

Featured Article

Data-rich or data-poor: Where should manufacturers focus their AI efforts?

Over the past year, manufacturers worldwide have made significant strides in adopting artificial intelligence technologies, moving beyond the initial hype to tangible implementations that deliver real business value.